SCOPUS 정보 검색 플랫폼

Diabetes Care

Volumn 36, Issue 8, 2013, Pages 2146-2147

Comparative effectiveness and the future of clinical research in diabetes

(1) Greenfield, Sheldon a

a UNIVERSITY OF CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLICLAZIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INDAPAMIDE PLUS PERINDOPRIL; INSULIN; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMPARATIVE EFFECTIVENESS; DIABETES MELLITUS; HUMAN; HYPOGLYCEMIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATIENT ATTITUDE; QUALITY OF LIFE; SOCIAL STATUS; TREATMENT OUTCOME; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN;

EID: 84885976181 PISSN: 01495992 EISSN: 19355548 Source Type: Journal
DOI: 10.2337/dc13-1221 Document Type: Note

Times cited : (5)

References (12)

1
- 84886015249
- Building useful evidence: Changing the clinical research paradigm to account for comparative effectiveness research
- Greenfield S, Kaplan SH. Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research. J Comp Eff Res 2012; 1:263-270
- (2012) J Comp Eff Res , vol.1 , pp. 263-270
- Greenfield, S.¹ Kaplan, S.H.²

2
- 68249103874
- Comparative effectiveness research: A report from the Institute of Medicine
- Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 2009; 151:203-205
- (2009) Ann Intern Med , vol.151 , pp. 203-205
- Sox, H.C.¹ Greenfield, S.²

3
- 84884550328
- Rationale and design of the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE)
- Nathan DM, Buse JB, Kahn SE, et al. Rationale and design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254-2261
- (2013) Diabetes Care , vol.36 , pp. 2254-2261
- Nathan, D.M.¹ Buse, J.B.² Kahn, S.E.³

4
- 84871995815
- Standards of medical care in diabetes- 2013
- American Diabetes Association
- American Diabetes Association. Standards of Medical Care in Diabetes- 2013. Diabetes Care 2013;36(Suppl. 1): S11-S66
- (2013) Diabetes Care , vol.36 , Issue.SUPPL. 1

5
- 79952273819
- Long-term effects of intensive glucose lowering on cardiovascular outcomes
- Gerstein HC, Miller ME, Genuth S, et al.; ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011; 364:818-828
- (2011) N Engl J Med , vol.364 , pp. 818-828
- Gerstein, H.C.¹ Miller, M.E.² Genuth, S.³

6
- 45149133036
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
- Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
- (2008) N Engl J Med , vol.358 , pp. 2560-2572
- Patel, A.¹ Macmahon, S.² Chalmers, J.³

7
- 0034871011
- A systematic review of the associations between dose regimens and medication compliance
- Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23:1296-1310
- (2001) Clin Ther , vol.23 , pp. 1296-1310
- Claxton, A.J.¹ Cramer, J.² Pierce, C.³

8
- 77953631151
- Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects
- Kaplan SH, Billimek J, Sorkin DH, Ngo- Metzger Q, Greenfield S.Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects. Med Care 2010;48(Suppl.):S9-S16
- (2010) Med Care , vol.48 , Issue.SUPPL.
- Kaplan, S.H.¹ Billimek, J.² Sorkin, D.H.³ Ngo-Metzger, Q.⁴ Greenfield, S.⁵

9
- 84871300520
- A look ahead at the future of diabetes prevention and treatment
- Arterburn DE, O'Connor PJ. A look ahead at the future of diabetes prevention and treatment. JAMA 2012;308:2517-2518
- (2012) JAMA , vol.308 , pp. 2517-2518
- Arterburn, D.E.¹ O'connor, P.J.²

10
- 33947617788
- Heterogeneity of treatment effects: Implications for guidelines, payment, and quality assessment
- Greenfield S, Kravitz R, Duan N, Kaplan SH. Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment. Am J Med 2007;120 (Suppl. 1):S3-S9
- (2007) Am J Med , vol.120 , Issue.SUPPL. 1
- Greenfield, S.¹ Kravitz, R.² Duan, N.³ Kaplan, S.H.⁴

11
- 72949106036
- Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: A cohort study
- Greenfield S, Billimek J, Pellegrini F, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med 2009;151:854-860
- (2009) Ann Intern Med , vol.151 , pp. 854-860
- Greenfield, S.¹ Billimek, J.² Pellegrini, F.³

12
- 84885980967
- Patient-Centered Outcomes Research Institute.Roundtable 25-26 April 2013, Washington, DC. Institute ofMedicine of the National Academies. Available from 15 May 2013
- Patient-Centered Outcomes Research Institute. Observational studies in a learning health system [Internet]. Roundtable 25-26 April 2013, Washington, DC. Institute ofMedicine of the National Academies. Available from http://iom.edu/Activities/Quality/VSRT/2013-APR-25.aspx. Accessed 15 May 2013
- Observational Studies in A Learning Health System [Internet]

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.